Walgreens Health Services > WHI > Medication management

Print

Our dual-purpose medication management programs are designed to improve patient therapeutic outcomes while proactively saving critical healthcare dollars. These programs promote appropriate utilization of expensive and potentially misprescribed or abused medications. Our goal is to help ensure that you can maximize your healthcare resources, while providing appropriate prescription coverage for your members.

Clinically based programs

• Tailored to meet your plan objectives and benefit design
• Hands-on approach to promoting clinically appropriate and cost-effective use of medications sets our programs above others in the marketplace

Program features

• Therapy-specific design based on more than 40 different protocols
• Start-to-finish clinically managed authorization process
• Quarterly reports available for clinical prior authorization, step care therapy, and override programs

Program options

• Prior authorization to identify expensive, potentially misprescribed, or abused medications
• Step care therapy to require utilization of an effective first-line agent before a more expensive alternative may be covered and/or dispensed
• Appropriateness of therapy to monitor drug quantities, age, and gender for appropriateness
• Override to provide alternatives for members seeking to obtain medications outside their standard prescription benefit design
• Plan prior authorization to go directly into our system in order to selectively override standard exclusions or limitations

Programs avaliable

• Acne-topical
• Actiq®
• ADHD and/or narcolepsy
• Anabolic steroids -- injectable
• Anabolic steroids -- oral
• Anabolic steroids -- topical
• Antiemetics -- oral
• Atopic dermatitis
• Benign prostatic hyperplasia (BPH)
• Botulinum toxins
• Butorphanol
• Byetta®
• Contraceptives
• Contraceptives -- injectable
• COX-2 inhibitors
• Crinone® 8 percent
• Dipeptidyl peptidase-4 (DPP-4) inhibitors
• Duragesic®
• Fentora®
• Formulary override
• Generic statins
• Impotency
• Insomnia
• Lamisil/Sporanox®
• Leukotrienes
• Lyrica®
• Mandatory 90-day supply override
• Migraine
• Non-benzodiazepine insomnia agents
• Obesity
• OTC non-sedating antihistamines
• OxyContin®
• Penlac
• Proton pump inhibitors
• Ranexa®
• Smoking cessation
• Selective serotonin reuptake inhibitors (SSRI)
• Strattera®
• Symlin®
• Wellbutrin® SR/XL